- Home
- CGC vs MIR Comparison
CGC vs MIR Comparison
Compare CGC & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- MIR
- Stock Information
- Founded
- CGC 2009
- MIR 2005
- Country
- CGC Canada
- MIR United States
- Employees
- CGC N/A
- MIR N/A
- Industry
- CGC Pharmaceuticals and Biotechnology
- MIR Industrial Machinery/Components
- Sector
- CGC Health Care
- MIR Technology
- Exchange
- CGC Nasdaq
- MIR Nasdaq
- Market Cap
- CGC 375.1M
- MIR 2.9B
- IPO Year
- CGC N/A
- MIR N/A
- Fundamental
- Price
- CGC $4.34
- MIR $14.44
- Analyst Decision
- CGC Sell
- MIR Strong Buy
- Analyst Count
- CGC 1
- MIR 2
- Target Price
- CGC $2.00
- MIR $14.00
- AVG Volume (30 Days)
- CGC 4.0M
- MIR 2.6M
- Earning Date
- CGC 11-07-2024
- MIR 10-29-2024
- Dividend Yield
- CGC N/A
- MIR N/A
- EPS Growth
- CGC N/A
- MIR N/A
- EPS
- CGC N/A
- MIR N/A
- Revenue
- CGC $209,768,750.00
- MIR $821,300,000.00
- Revenue This Year
- CGC N/A
- MIR $7.10
- Revenue Next Year
- CGC $9.76
- MIR $5.63
- P/E Ratio
- CGC N/A
- MIR N/A
- Revenue Growth
- CGC N/A
- MIR 8.34
- 52 Week Low
- CGC $2.76
- MIR $6.70
- 52 Week High
- CGC $14.92
- MIR $14.80
- Technical
- Relative Strength Index (RSI)
- CGC 44.42
- MIR 79.86
- Support Level
- CGC $4.06
- MIR $10.92
- Resistance Level
- CGC $4.51
- MIR $14.80
- Average True Range (ATR)
- CGC 0.19
- MIR 0.58
- MACD
- CGC 0.07
- MIR 0.23
- Stochastic Oscillator
- CGC 57.65
- MIR 90.92
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.